The embryonic stem cell factor Sox2, implicated in development, pluripotency, and cancer biology [43], is also found in breast stem/progenitor cells [30] and is highly expressed in breast tumors that have developed resistance to endocrine therapy and display poor clinical outcome [29]. Here, SOX2 is linked to breast neoplasm.